Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bopei Cui

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Signal Transduction and Targeted Therapy|May 19, 2021
COVID-19 vaccines: progress and understanding on quality control and evaluationQunying Mao, Miao Xu, Qian He, et al.
Human Vaccines & Immunotherapeutics|December 19, 2019
Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10Kelei Li, Fangyu Dong, Bopei Cui, et al.
Biochemistry and Biophysics Reports|January 16, 2026
Anti-tumor analysis of the RIG-I agonist in <i>vitro</i> and <i>in vivo</i>Qian Wang, Ziyang Song, Bopei Cui, et al.
Virologica Sinica|March 15, 2022
Construction and verification of an infectious cDNA clone of coxsackievirus B5Lifang Song, Bopei Cui, Jinghuan Yang, et al.
Emerging Microbes & Infections|November 22, 2018
A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5Qunying Mao, Xiaotian Hao, Yalin Hu, et al.
Medcomm|December 7, 2022
Mixed formulation of mRNA and protein-based COVID-19 vaccines triggered superior neutralizing antibody responsesJialu Zhang, Qian He, Xujia Yan, et al.
Viruses|May 27, 2023
A Novel Targeted RIG-I Receptor 5'Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein VaccineYu Bai, Chaoqiang An, Xuanxuan Zhang, et al.
Human Vaccines & Immunotherapeutics|February 9, 2019
A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challengeRuixiao Du, Qunying Mao, Yalin Hu, et al.
Viruses|September 23, 2022
A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein VaccineDong Liu, Chaoqiang An, Yu Bai, et al.
Emerging Microbes & Infections|March 28, 2022
Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRVQian Wang, Ziyang Song, Jinghuan Yang, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Signal Transduction and Targeted Therapy|May 19, 2021
COVID-19 vaccines: progress and understanding on quality control and evaluationQunying Mao, Miao Xu, Qian He, et al.
Human Vaccines & Immunotherapeutics|December 19, 2019
Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10Kelei Li, Fangyu Dong, Bopei Cui, et al.
Biochemistry and Biophysics Reports|January 16, 2026
Anti-tumor analysis of the RIG-I agonist in <i>vitro</i> and <i>in vivo</i>Qian Wang, Ziyang Song, Bopei Cui, et al.
Virologica Sinica|March 15, 2022
Construction and verification of an infectious cDNA clone of coxsackievirus B5Lifang Song, Bopei Cui, Jinghuan Yang, et al.
Emerging Microbes & Infections|November 22, 2018
A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5Qunying Mao, Xiaotian Hao, Yalin Hu, et al.
Medcomm|December 7, 2022
Mixed formulation of mRNA and protein-based COVID-19 vaccines triggered superior neutralizing antibody responsesJialu Zhang, Qian He, Xujia Yan, et al.
Viruses|May 27, 2023
A Novel Targeted RIG-I Receptor 5'Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein VaccineYu Bai, Chaoqiang An, Xuanxuan Zhang, et al.
Human Vaccines & Immunotherapeutics|February 9, 2019
A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challengeRuixiao Du, Qunying Mao, Yalin Hu, et al.
Viruses|September 23, 2022
A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein VaccineDong Liu, Chaoqiang An, Yu Bai, et al.
Emerging Microbes & Infections|March 28, 2022
Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRVQian Wang, Ziyang Song, Jinghuan Yang, et al.
Pageof 2